132
11
8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T13725 | Hsp90-Cdc37-IN-1 | Others | |
Hsp90-Cdc37-IN-1 is an Hsp90-Cdc37 interaction disruptor (IC50: 140 nM) that inhibit cell migration and reverse drug resistance. | |||
T73011 | HSP90-IN-20 | ||
HSP90-IN-20, a potent inhibitor of HSP90, exhibits an IC50 of ≤10 μM, indicating its potential application in cancer research. | |||
T63205 | HSP90-IN-13 | ||
HSP90-IN-13 (compound 5k) is a potent broad-spectrum inhibitor of HSP90 with an IC50 of 25.07 nM. HSP90-IN-13 has multitargeted activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 blocks the MCF-7 cell cycle ... | |||
T73037 | HSP90-IN-18 | ||
HSP90-IN-18 is a potent inhibitor of heat shock protein 90 (Hsp90), demonstrating significant inhibitory activity with an IC50 value of 0.39 μM. It is applicable in the research of viral infections, neurodegenerative dis... | |||
T61938 | HSP90-IN-12 | ||
Vibsanin A analog C (VAC) is an anti-cancer compound, which shows anti-proliferative effect on various cancer cell lines, and the anti-proliferative activity is the strongest among vibsanin A analogues. VAC fluctuated th... | |||
T78863 | HSP90-IN-25 | HSP | |
HSP90-IN-25 (compound 4a) is an inhibitor targeting HSP90, specifically impeding its ATPase function [1]. | |||
T63528 | HSP90-IN-11 | ||
HSP90-IN-11 is a potent inhibitor of HSP90 and induces significant accumulation of the sub-G1 population. HSP90-IN-11 has a potent HSP90α inhibitory effect comparable to that of AUY-922 (Luminespib). In CRC and NSCLC cel... | |||
T63828 | Hsp90-IN-16 | ||
Hsp90-IN-16 is an HSP90 inhibitor that acts effectively and highly selectively on HER2-positive cancer cells.Hsp90-IN-16 inhibits the proliferation of HCC1954 breast cancer cells with an IC50 value of 6 μM.Hsp90-IN-16 in... | |||
T79083 | HSP90-IN-22 | HSP | |
HSP90-IN-22 (Compound 35) is an Hsp90 inhibitor exhibiting antiproliferative activity, with IC50 values of 3.65 μM in MCF7 breast cancer cells and 2.71 μM in SKBr3 breast cancer cells. | |||
T73038 | HSP90-IN-19 | HSP | |
HSP90-IN-19 is a potent inhibitor of heat shock protein 90 (Hsp90), exhibiting inhibitory activity with an IC50 of 0.27 μM. It is utilized in the research of viral infections, neurodegenerative diseases, and inflammation... | |||
T78942 | HSP90-IN-23 | HSP | |
HSP90-IN-23 (Comp 12-1), a heat shock protein 90 (HSP90) inhibitor, exhibits potent activity with an IC50 of 9nM. It promotes apoptosis in tumor cells and arrests their cell cycle at the G0/G1 phase, making it applicable... | |||
T27991 | MDK-0757 | Hsp90-IN-89,MDK0757 | |
MDK-0757 is a novel inhibitor of heat shock protein 90 (Hsp90). | |||
T62307 | Aha1/Hsp90-IN-1 | ||
Aha1/Hsp90-IN-1 (Compound 17) is an inhibitor of the Aha1/Hsp90 complex and has an inhibitory effect on tau protein aggregation.Aha1/Hsp90-IN-1 disrupts the Aha1/Hsp90 interaction (IC50: 3.32 μM). | |||
T63529 | HDAC/HSP90-IN-3 | ||
HDAC/HSP90-IN-3 is a selective and potent dual inhibitor of fungal Hsp90 (IC50: 0.83 μM) and HDAC (IC50: 0.91 μM), exhibiting antifungal effects against azole-resistant Candida albicans. HDAC/HSP90-IN-3 exhibits inhibito... | |||
T62163 | Hsp90-IN-15 | ||
Hsp90-IN-15 is an Hsp90 inhibitor with anticancer effects. Hsp90-IN-15 blocks the cell cycle in S phase, induces apoptosis and reduces Hsp90 expression in Hela cells. | |||
T82166 | HSP90-IN-27 | HSP | |
HSP90-IN-27, also known as compound 19, is an inhibitor of HSP90 [1]. | |||
T63827 | HSP90-IN-10 | ||
HSP90-IN-10 is a potent inhibitor of HSP90. HSP90-IN-10 exhibits potent anti-proliferative effects on HCC1954 breast cancer cells (IC50: 6 μM). hSP90-IN-10 induces apoptosis without inhibiting the growth of normal epithe... | |||
T72996 | Hsp90-IN-17 | ||
Hsp90-IN-17 (Example 5) is an inhibitor of HSP90, applicable in researching proliferative diseases, including cancer and neurodegenerative conditions. | |||
T61904 | HSP90-IN-14 | ||
HSP90-IN-14 (compound 4) is an effective Hsp90 inhibitor (Kd=0.26 μM). In MDCK cells, HSP90-IN-14 showed anti-influenza virus activity, the EC50 against influenza A/H3N2, A/H1N1 and B virus was 2.6, 3.9 and 17 μM, respec... | |||
T64263 | HSP90-IN-9 | ||
HSP90-IN-9 is a selective and potent HSP90 inhibitor.HSP90-IN-9 exhibits a dose-dependent fungicidal effect.HSP90-IN-9 in combination with FLC inhibits fungal biofilm formation and fungal morphological changes.HSP90-IN-9... | |||
T63531 | HDAC6/HSP90-IN-1 | ||
HDAC6/HSP90-IN-1 is a potent and selective dual inhibitor of HDAC6 (IC50: 4.3 nM) and HSP90 (IC50: 46.8 nM).HDAC6/HSP90-IN-1 downregulates PD-L1 expression in INF-γ-treated H1975 lung cancer cells.HDAC6/HSP90-IN-1 exhibi... | |||
T64261 | HDAC/HSP90-IN-4 | ||
HDAC/HSP90-IN-4 significantly inhibited HDAC and HSP90 activity, with compound 20 (HDACIC50= 194 nM; HSP90αIC50= 153 nM) and compound 26 ((HDACIC50= 360 nM; HSP90αIC50= 77 nM) having the strongest HDAC and HSP90α inhibit... | |||
T72225 | Hsp90-IN-17 hydrochloride | ||
Hsp90-IN-17 (Example 5) hydrochloride, an HSP90 inhibitor, has potential applications in the research of proliferative conditions including cancer and neurodegenerative diseases. | |||
T72780 | HSP90/mTOR-IN-1 | ||
HSP90/mTOR-IN-1 is an effective and orally administrable inhibitor targeting both Hsp90 and mTOR, displaying IC50 values of 69 nM and 29 nM, respectively. This compound inhibits the proliferation of SW780 cells by overly... | |||
T61315 | HDAC6/HSP90-IN-2 | ||
HDAC6/HSP90-IN-2 (compound 6e) is a dual inhibitor targeting HDAC6 and Hsp90, exhibiting IC50 values of 105.7 nM and 61 nM, respectively. It is primarily utilized in cancer research [1]. | |||
T73835 | PROTAC HSP90 degrader BP3 | ||
PROTAC HSP90 degrader BP3 potently and selectively degrades HSP90 through a CRBN-dependent mechanism. It effectively diminishes HSP90 protein levels in MCF-7 cells with a half-maximal degradation concentration (DC50) of ... | |||
T79486 | MAO A/HSP90-IN-1 | Monoamine Oxidase | |
MAO A/HSP90-IN-1 (4-b) is a dual inhibitor of MAO A and HSP90, exhibiting IC50 values of 1.77 μM in glioblastoma (GBM) GL26 cells and 0.019 μM against HSP90α. This compound impairs the activities of MAO A, disrupts HSP90... | |||
T79487 | MAO A/HSP90-IN-2 | Monoamine Oxidase | |
MAO A/HSP90-IN-2 (compound 4-C), a dual inhibitor of HSP90 and MAO A, exhibits IC50 values of 0.016 μM for MAO A and 4.58 μM for HSP90. This compound not only enhances HSP70 expression but also diminishes HER2 and phosph... | |||
T8858 | DTHIB | HSP | |
DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation. | |||
T9202 | DDO-5936 | HSP | |
DDO-5936 is a potent and specific HSP90-Cdc37 PPI inhibitor. | |||
T8958 | PU-H54 | GPR | |
PU-H54 is a purine-based inhibitor of Grp94. It is a Grp94-selective resorcinol-based inhibitor isolated through probing of the exclusive binding region of S2 subpocket in Grp94. | |||
T6442 | CH5138303 | HSP | |
CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM. | |||
T79323 | PROTAC Hsp90α degrader 1 | HSP | |
Compound X10g (PROTAC Hsp90α degrader 1) is a selective agent targeting Hsp90α for degradation and is utilized in breast cancer research. It demonstrates inhibitory effects on the proliferation of breast cancer cell line... | |||
T6609 | NMS-E973 | HSP | |
NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases. | |||
T2258 | VER-50589 | VER50589 | Apoptosis , HSP |
VER-50589 is a potent HSP90 inhibitor. | |||
T3454 | VER-49009 | CCT 129397 | HSP |
VER-49009 (CCT 129397) is a potent Hsp90 inhibitor(IC50 of 25 nM and Kd of 78 nM). | |||
T20890 | Alvespimycin | 17-DMAG,KOS1022,KOS 1022,KOS-1022 | HSP |
Alvespimycin (17-DMAG) is a potent Hsp90 inhibitor with potential anticancer activity, which acts by binding to Hsp90. | |||
T2268 | VER49009 | CCT0129397,VER 49009,VER-49009 | HSP |
VER49009 (CCT0129397) is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM). | |||
T6305 | SNX2112 | SNX-2112,PF 04928473,SNX 2112 | HSP |
SNX2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM. | |||
T6248 | XL888 | HSP | |
XL888 is an ATP-competitive inhibitor of Hsp90 ( IC50: 24 nM). Heat shock protein 90 (Hsp90) is a chaperone that maintains the functionality of client proteins involved in cell proliferation, cell cycling, and apoptosis.... | |||
T6297 | Alvespimycin hydrochloride | BMS 826476,NSC 707545,KOS-1022,17-DMAG hydrochloride,Alvespimycin (17-DMAG) HCl | Apoptosis , HSP |
Alvespimycin hydrochloride (BMS 826476) is a potent HSP90 inhibitor with IC50 of 62 nM. Phase 2. | |||
T27193 | DN401 | DN 401,DN-401 | HSP |
DN401 is a potent TRAP1 and Hsp90 Inhibitor( IC50 = 79 nM for TRAP1, IC50 = 698 nM for Hsp90) with potent anticancer activity. | |||
T36123 | 3-Phenyltoxoflavin | ZINC267655,Phenyltoxoflavin | HSP |
3-Phenyltoxoflavin (Phenyltoxoflavin) is an inhibitor of HSP90 (Kd = 585 nM) with anti-cancer activity. | |||
T6960 | PU-H71 | HSP | |
PU-H71 is an effective selective HSP90 inhibitor with an IC50 of 51 nM. | |||
T13547L | AMP-PCP disodium | HSP | |
AMP-PCP disodium is an ATP analogue with binding affinity to the N-terminal domain of Hsp90, with a Kd value of 3.8 μM. The binding of AMP-PCP disodium contributes to the formation of an active homodimer of Hsp90. | |||
T2114 | VER-82576 | NVP-BEP800 | HSP |
VER-82576 (NVP-BEP800), a synthetic HSP90β inhibitor (IC50: 58 nM), exhibits >70-fold selectivity against Hsp90 family members Trap-1 and Grp94. | |||
T4342 | PF-04929113 Mesylate | PF-04929113 (Mesylate),SNX-5422 Mesylate | HSP , HER |
PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37 nM). | |||
T2286 | BIIB021 | BIIB 021,CNF2024,BIIB-021 | HSP , Autophagy |
BIIB021 (CNF2024) is an orally-available, fully synthetic inhibitor of HSP90(Ki=1.7 nM, EC50=38 nM). | |||
T6284 | Onalespib | AT13387,Onalespib (AT13387) | HSP |
Onalespib (AT13387) is a synthetic, orally bioavailable, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity. Onalespib selectively binds to Hsp90, thereby inhibiting its chap... | |||
T1989 | Luminespib | AUY922,VER-52296,NVP-AUY922 | Apoptosis , HSP , Autophagy |
Luminespib (VER-52296) is a new-type inhibitor of HSP90 (IC50s: 7.8/21 nM for HSP90α/β in cell free assay). |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21883 | Gedunin | HSP | |
Gedunin is an important limonoid present in several genera of the Meliaceae family, mainly in seeds. Gedunin is an Hsp90 inhibitor, and inhibits ovarian cancer cell proliferation. | |||
T6343 | Geldanamycin | NSC 122750 | HSP , Influenza Virus , Tyrosine Kinases , Antibacterial , Antibiotic |
Geldanamycin, an HSP90 inhibitor (Kd: 1.2 μM), specifically disrupts glucocorticoid receptor (GR)/HSP association. | |||
T6290 | Tanespimycin | 17-AAG,CP 127374,NSC 330507,KOS 953 | Apoptosis , Mitophagy , HSP , Antibacterial , Antibiotic , Autophagy |
Tanespimycin (KOS 953) (17-AAG) is an inhibitor of Hsp90 that selectively inhibits BT474 tumor cell Hsp90 (IC50: 5 nM). | |||
T8189 | Dihydroberberine | Potassium Channel , HSP , HER | |
Dihydroberberine has anti-atherosclerotic, anti-inflammatory, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interacti... | |||
T5826 | Eupalinolide A | HSP | |
Eupalinolide B is a natural product ,and demonstrates potent cytotoxicity against A-549, BGC-823, SMMC-7721, and HL-60 tumour cell lines. | |||
TJS0928 | Calenduloside E | Silphioside F | Others |
Calenduloside E (Silphioside F) exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intesti... | |||
T0974 | Novobiocin Sodium | Albamycinsodium,Cathomycin,Albamycin | Potassium Channel , DNA gyrase , Topoisomerase , Antibacterial , Antibiotic , ABC , Autophagy |
Novobiocin Sodium (Albamycinsodium) binds to DNA gyrase and blocks adenosine triphosphatase (ATPase) activity. Novobiocin sodium is an antibiotic compound derived from Streptomyces niveus. It has a chemical structure sim... | |||
T16719 | Radicicol | Monorden | HSP |
Radicicol is an antifungal antibiotic, impairs mitochondrial replication by targeting P. falciparum topoisomerase VIB. Radicicol is an inhibitor of Hsp90 (IC50: 1 μM). Radicicol binds to the ATPase domain of Hsp90 and pr... | |||
T5136 | Kongensin A | ||
Kongensin A is an effective heat shock protein 90 (HSP90) inhibitor that has potential anti-necroptosis and anti-inflammation applications. | |||
TN2360 | Falcarinol | Falcarinol,Panaxynol | HSP |
Falcarinol, also known as Panaxynol, is a naturally occurring compound that acts as an orally active inhibitor of Hsp90. It effectively targets both the N-terminal and C-terminal regions of Hsp90, displaying high selecti... | |||
T68802 | Vibsanin A | ||
Vibsanin A, an activator of protein kinase C (PKC) and an inhibitor of HSP90, demonstrates anti-proliferative effects on human cancer cell lines. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01478 | HSP90 alpha Protein, Human, Recombinant | Human | E. coli |
HSP90 alpha Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 22.6 kDa and the accession number is K9JA46. | |||
TMPY-06846 | HSP90 alpha Protein, Mouse, Recombinant (His) | Mouse | Baculovirus Insect Cells |
HSP90 alpha Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 87.19 kDa and the accession number is NP_032328.2. | |||
TMPY-06845 | HSP90 alpha Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
HSP90 alpha Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 87.06 kDa and the accession number is NP_005339.3. | |||
TMPH-01429 | HSP90AA1 Protein, Human, Recombinant (His) | Human | E. coli |
HSP90AA1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 36.0 kDa and the accession number is P07900. | |||
TMPH-03113 | HSP90AA1 Protein, Pig, Recombinant (His) | Sus scrofa (Pig) | Baculovirus Insect Cells |
HSP90AA1 Protein, Pig, Recombinant (His) is expressed in Baculovirus insect cells with N-6xHis tag. The predicted molecular weight is 19.7 kDa and the accession number is O02705. | |||
TMPH-01430 | HSP90AB1 Protein, Human, Recombinant (His & Myc) | Human | E. coli |
HSP90AB1 Protein, Human, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 88.1 kDa and the accession number is P08238. | |||
TMPJ-01386 | STUB1 Protein, Human, Recombinant | Human | E. coli |
E3 Ubiquitin-Protein Ligase CHIP is a cytoplasmic protein. CHIP is highly expressed in skeletal muscle, heart, pancreas, brain and placenta. CHIP interacts with the molecular chaperones Hsc70-Hsp70 and Hsp90 through its ... | |||
TMPJ-01411 | HSPB11 Protein, Human, Recombinant (His) | Human | E. coli |
Heat Shock Protein β-11 (HSPB11) is a stress-responsive protein that is required to deal with proteotoxic stresses. HSPB11 is composed of an IFT complex B composed of IFT88, IFT57, TRAF3IP1, IFT52, IFT27, HSPB11 and IFT2... |